CompaniesBetaStem Therapeutics

BetaStem Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

5

As Collaborator

0

Total Enrollment

1,766

By Phase

NA: 3PHASE3: 2

By Status

COMPLETED: 2ACTIVE_NOT_RECRUITING: 2TERMINATED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
Today
NCT04886388
NCT05094401
NCT05266625
NCT05302050
Hover over trial bars to see details

Recent Trials

NCT05357248Lead Sponsor
Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASH
NACompleted
22 participants
Started: Apr 10, 2022 · Completed: Dec 7, 2022
NCT05302050Lead Sponsor
A Cognitive Behavioral Digital Therapeutic InterventiON for Glycemic Control in Type 2 Diabetes Mellitus
NAActive, not recruiting
500 participants
Started: Mar 7, 2022 · Completed: Dec 1, 2025
NCT05266625Lead Sponsor
Digital Therapeutic Based Investigation to Improve Glycemic Control in Patients With Type 2 Diabetes and Residual Hyperglycemia on Stable Medical Therapy
NAActive, not recruiting
500 participants
Started: Feb 14, 2022 · Completed: Nov 30, 2025
NCT05094401Lead Sponsor
Use of an Investigational Digital Therapeutic in Patients With Type 2 Diabetes
PHASE3Terminated
76 participants
Started: Oct 4, 2021 · Completed: Apr 1, 2023
NCT04886388Lead Sponsor
Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes
PHASE3Completed
668 participants
Started: Apr 22, 2021 · Completed: Sep 27, 2022